Pharmaceutical Services M&A Transactions

Lexitas Pharma Services acquires Erie Retina Research and related entities, enhancing its specialized ophthalmology clinical trial services and retina research expertise.

Cohere strengthens its enterprise AI platform with Reliant AI acquisition, boosting capabilities in secure biopharma and healthcare solutions.

SERB Pharmaceuticals secures European and MENA rights for Hansa Biopharma's Idefirix® (imlifidase) in a €115M deal, enhancing kidney transplant options.

SERB Pharmaceuticals secures European and MENA rights for Hansa Biopharma's imlifidase, a key therapy for highly sensitized kidney transplant patients, in a €115M deal.

Cohere strengthens its healthcare AI capabilities by acquiring Reliant AI, integrating specialized biomedical data and expertise into its enterprise platform.

Cohere strengthens its biopharma AI capabilities by acquiring Reliant AI, integrating advanced technology for drug discovery and R&D. Learn more.

Private equity firms EQT and IDG Capital are in advanced talks to acquire Swiss peptide therapeutics manufacturer PolyPeptide, valued near $1.6 billion.

EQT AB and IDG Capital are shortlisted to acquire Swiss peptide drug manufacturer PolyPeptide Group, valued at $1.6 billion. Altaris also remains in talks.

Cumming Group enhances its Advanced Technologies division with the acquisition of RGD Project Management, boosting its capabilities in the US life sciences manufacturing sector.

OrganaBio secures Excellos' assets, establishing a bicoastal cell therapy CDMO to address critical manufacturing and supply chain needs.

Zydus Worldwide DMCC, a Zydus Lifesciences subsidiary, acquires Assertio Holdings for $166.4M in an all-cash transaction, offering a substantial premium.

BioPhorum enhances its implementation services by acquiring PharmaX Solutions, boosting digital transformation and operational efficiency in the life sciences sector.

Angelini Pharma acquires Catalyst Pharmaceuticals for $4.1B, significantly expanding its U.S. rare disease and neurological disorder footprint.

Rigi Capital acquires Super's Diana, a Catalan animal health company, with support from Aurica Search Fund. Details on deal and market impact.

QuantWare secures $178M Series B led by Intel Capital, IQT, and ETF Partners to expand quantum processor manufacturing and develop next-gen qubit technology.